Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Recruiting2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT02917083Phase 1Recruiting
CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
Hodgkin's LymphomaNon-Hodgkin Lymphoma
PrincipalinvestigatorStart date: 2017-05-08
NCT01853631Phase 1Recruiting
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
Acute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Principalinvestigator

Research Network

Collaboration Network

11 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Helen Heslop, MD

Baylor College of Medicine

Moderately Similar
17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+1 more

Worked with same sponsors:

Baylor College of MedicineCenter for Cell and Gene Therapy, Baylor College of Medicine+1 more
Collaborated on 2 trials
Similarity Score48%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Moderately Similar
24 trials

Shared therapeutic areas:

Leukemia, Lymphocytic, Chronic, B-CellHodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more
Similarity Score30%

Yves Beguin, MD, PhD

CHU-ULg

Moderately Similar
7 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+1 more
Similarity Score30%

Arnon Nagler, MD

Chaim Sheba Medical Center

Related
12 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score23%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Hodgkin DiseasePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score23%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score15%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-Cell
Similarity Score15%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

Hodgkin DiseaseLymphoma, Non-Hodgkin
Similarity Score15%

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score8%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02917083Phase 1PrincipalInvestigator

CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)

Hodgkin's LymphomaNon-Hodgkin Lymphoma
Recruiting
NCT01853631Phase 1PrincipalInvestigator

Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)

Acute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Recruiting

All 2 trials loaded